Navigation Links
Michael W. Marine Appointed CEO of Sabin Vaccine Institute

Former diplomat takes reins of leading vaccine development and advocacy organization

WASHINGTON, April 28 /PRNewswire-USNewswire/ -- Michael W. Marine, former U.S. Ambassador to the Socialist Republic of Vietnam, has been appointed as the new chief executive officer of the Sabin Vaccine Institute, announced Sabin's Chairman of the Board of Trustees Mort Hyman and President Dr. Peter Hotez.  Ambassador Marine served 32 years in the U.S. State Department's Foreign Service and was a six time recipient of the Department's Superior Honor Award.


"Michael Marine will be a tremendous asset to our team," said Dr. Hotez. "Sabin and our programs have achieved unprecedented success and grown rapidly in recent years. Michael has the experience and commitment to sustain that growth while ensuring that we continue to invest in our infrastructure and our mission."

Michael Marine joined Sabin's leadership team in December 2009 after serving eight months on the Joint Action Committee of the Global Network for Neglected Tropical Diseases, a major initiative of Sabin that seeks to raise awareness, political will, and funding necessary to control and eliminate the most common neglected tropical diseases (NTDs).

"I am honored to work with such a talented team and excited to build on Sabin's success," Marine said. "I've lived in many places where access to basic health resources is considered a privilege and survival is often a question. As CEO, it's my goal to ensure that Sabin contributes to efforts to further accelerate access to vaccines and treatments that prevent and cure infectious and neglected tropical diseases for those who need them."

Prior to serving as ambassador to Vietnam, Michael Marine was Deputy Chief of Mission at the U.S. embassies in Beijing, China; Nairobi, Kenya and Suva, Fiji. He also served in program direction positions in U.S. diplomatic posts in Moscow, Russia; Bonn, Germany and Guangzhou, China. Marine enlisted in the U.S. Marine Corps in 1967 and completed his service with the rank of Captain in 1971. He graduated Phi Beta Kappa and summa cum laude from the University of California at Santa Barbara in 1974 with a degree in Asian Studies.  He entered the Foreign Service a year later.

"Michael Marine's appointment to CEO was unanimously approved by the board," said Mr. Hyman. "His many years of diplomatic experience in countries struggling with difficult health care challenges, particularly Africa and Asia, provides him a unique perspective that will be of tremendous value to Sabin and will add significant strength to our team."

About Sabin Vaccine Institute

Sabin Vaccine Institute is a 501(c)(3) non-profit organization dedicated to reducing human suffering from infectious and neglected diseases. Through its efforts in vaccine research, development and advocacy, Sabin works to provide greater access to vaccines and essential medicines for millions mired in pain, poverty and despair. Founded in 1993 in honor of Dr. Albert B. Sabin, discoverer of the oral polio vaccine, the Sabin Vaccine Institute works with prestigious institutions, scientists, medical professionals, and organizations to provide short and long-term solutions that result in healthier individuals, families and communities around the globe.

SOURCE Sabin Vaccine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams Pre-Clinical Development of Neuroprotective Parkinsons Therapies
2. D-M-S Holdings, Inc. Announces the Filing of a Lawsuit Against Veridian Healthcare, LLC, Steven M. Bisulca and Michael Mazza
3. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
4. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
5. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
6. Michael J. Fox Foundation-Funded Team Pursuing Glutamate-Based Treatment for Parkinsons Disease Hits Major Milestone
7. Michael J. Fox Foundation Commits Up to $12 Million for Targeted Parkinsons Therapeutic Development in 2010
8. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
9. Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinsons Therapeutic Targets
10. Michael J. Fox Foundation Commits up to $6.5 Million in Funding for Critical Challenges in Parkinsons Disease
11. Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinsons Disease
Post Your Comments:
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):